GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple treatment regimens in newly diagnosed and recurrent glioblastoma Meeting Abstract
| Authors: | Weller, M.; Ellingson, B.; Alexander, B.; Wen, P.; Sulman, E.; Colman, H.; Berry, D.; Tanner, K.; Khasraw, M.; Lim, M.; Perry, J.; Lassman, A.; Cloughesy, T.; Yung, W. K. A.; Lee, E. Q.; Mellinghoff, I.; Gordon, G.; de Groot, J.; Mikkelsen, T.; Cavenee, W.; Nelli, A.; Buxton, M.; Li, W. |
| Abstract Title: | GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple treatment regimens in newly diagnosed and recurrent glioblastoma |
| Meeting Title: | 17th Meeting of the European Association of Neuro-Oncology |
| Journal Title: | Neuro-Oncology |
| Volume: | 24 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 15-18 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | ii73 |
| Language: | English |
| ACCESSION: | WOS:000850365500254 |
| DOI: | 10.1093/neuonc/noac174.254 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P11.65.B -- Source: Wos |
